Posterolateral lumbar fusion using Escherichia coli-derived rhBMP-2/hydroxyapatite in the mini pig

Spine J. 2014 Dec 1;14(12):2959-67. doi: 10.1016/j.spinee.2014.06.007. Epub 2014 Jun 14.

Abstract

Background context: Hydroxyapatite (HA) is used as a bone graft extender for posterolateral spinal fusion in human. It is also useful as a recombinant human bone morphogenetic protein (rhBMP)-2 carrier because of its high affinity for rhBMP-2.

Purpose: To assess the osteoinductivity of Escherichia coli-derived rhBMP-2 (E-BMP-2) using HA granules as a carrier and to evaluate the bone-forming ability depending on the different dosages of E-BMP-2.

Study design: A mini-pig lumbar posterolateral fusion model using microcomputed tomography (μCT) scanning.

Patient sample: Thirty-one adult male mini pigs were randomized into a single control group (n=8) without E-BMP-2 and two experimental groups with two different doses of E-BMP-2 (1 mg per side, n=8 and 3 mg per side, n=15).

Outcome measures: Outcome was measured by plain radiography, manual palpation, CT, three-dimensional μCT, and histologic examinations.

Methods: Bilateral intertransverse process arthrodesis was performed, and E-BMP-2 (0, 1.0, 3.0 mg per side) was implanted into the intertransverse space using HA granules as a carrier.

Results: Three mini pigs were removed because of death. Among 28 experimental subjects, 19 animals achieved solid bony union. The fusion rates were 37.5% for control group, 71.4% for 1 mg group, and 84.6% for 3 mg group. Fusion rates were significantly different among groups (p=.031). However, there was no statistically significant difference in fusion rates between 1 and 3 mg groups (p=.587). Thirty-eight intertransverse fusion masses of 19 subjects underwent μCT scanning. The bone volumes determined by μCT were 12,603±3,240 mm(3) for control group, 18,718±3,000 mm(3) for 1 mg group, and 26,768±7,256 mm(3) for 3 mg group, and the difference between groups was statistically significant (p<.001).

Conclusions: This study shows that E-BMP-2 has osteoinductive activity in dose-dependent fashion, and porous HA granule is suitable for E-BMP-2 carrier in a porcine posterolateral fusion model. These preliminary findings suggest that E-BMP-2-adsorbed porous HA granules could be a novel effective bone graft substitute.

Keywords: Escherichia coli–derived rhBMP-2; Hydroxyapatite; Mini pig; Osteoinductivity; Posterolateral fusion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Morphogenetic Protein 2 / administration & dosage
  • Bone Morphogenetic Protein 2 / therapeutic use*
  • Bone Transplantation / methods*
  • Drug Carriers / chemistry
  • Durapatite / chemistry
  • Humans
  • Lumbar Vertebrae / surgery
  • Male
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use
  • Spinal Fusion / methods*
  • Swine
  • Swine, Miniature
  • Transforming Growth Factor beta / administration & dosage
  • Transforming Growth Factor beta / therapeutic use*

Substances

  • Bone Morphogenetic Protein 2
  • Drug Carriers
  • Recombinant Proteins
  • Transforming Growth Factor beta
  • recombinant human bone morphogenetic protein-2
  • Durapatite